NCT06125769 2026-03-16
LITALHICA
Azienda Sanitaria Ospedaliera
Phase NA Recruiting
Clinical Trials
11 trialsNCT07454486 2026-03-06
TRACE-BTC
Aarhus University Hospital
Not yet recruiting
NCT06109779 2026-03-04
Rilvegostomig + Chemotherapy as Adjuvant Therapy for Biliary Tract Cancer After Resection (ARTEMIDE-Biliary01)
AstraZeneca
Phase 3 Active not recruiting
NCT06178588 2026-02-24
Sacituzumab Govitecan for the Treatment for Patients With Locally Advanced, Recurrent, or Metastatic Cholangiocarcinoma
University of Kansas Medical Center
Phase 2 Active not recruiting
NCT05430698 2026-02-09
PD-1 Antibody Plus GEMOX as Postoperative Adjuvant Therapy in Perihilar Cholangiocarcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 2 Recruiting
NCT06739252 2026-01-28
Perioperative Treatment of High-risk Resectable CCA With HAIC Plus A+T: Neobrave CCA
Peking University
Phase 2 Terminated
NCT05993429 2026-01-26
Diagnostic Efficacy of EUS-FNA/B Versus ERCP With or Without POCS-TB in Patients With Suspected Hilar Cholangiocarcinoma
Qilu Hospital of Shandong University
Completed
NCT07326189 2026-01-16
PHAE-PHCC
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase NA Not yet recruiting
NCT07311798 2025-12-31
Impact of Vascular Resection on Survival and Postoperative Outcomes in Patients With Hilar Cholangiocarcinoma: A Retrospective Study
Tongji Hospital
Not yet recruiting
NCT03104569 2025-12-26
Effect of 37℃ Non-ionic Contrast Agent During ERCP Procedure in Hilar Cholangiocarcinoma
Hepatopancreatobiliary Surgery Institute of Gansu Province
Phase NA Not yet recruiting
NCT06420349 2025-12-22
NXP800 for the Treatment of Patients With Advanced or Metastatic Cholangiocarcinoma
Mayo Clinic
Phase 1 Terminated